Bausch + Lomb is a global eye-health company whose brands span contact lenses, lens-care solutions, ophthalmic pharmaceuticals and surgical products for cataract and other vision procedures. The Bausch + Lomb name is widely recognized among consumers and eye-care professionals. It sells through optical retail, pharmacies, hospitals and eye-care practitioners worldwide. Its breadth across consumer vision care and professional ophthalmology sets it apart from single-segment peers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,278 | — | -62 | — |
| Q3 2025 | 1,281 | — | -28 | — |
| Q4 2025 | 1,405 | — | -58 | — |
| Q1 2026 | 1,244 | — | -71 | — |
| Q2 2026 | 1,394 | 9.1% | -14 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: WPP plc (WPP), Builders FirstSource, Inc. (BLDR), PJT Partners Inc. (PJT), GATX Corporation (GATX), Black Hills Corporation (BKH), Home BancShares, Inc. (HOMB)